Current approaches to explain the virulence of acinetobacter baumannii;Acinetobacter baumannii Virülansinin Açiklanmasinda Güncel Yaklaşimlar

Mikrobiyoloji Bulteni

Volumn 45, Issue 2, 2011, Pages 371-380

  Aşik, Gülşah ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Acinetobacter baumannii; Multi resistance; Nosocomial infection; Virulence

Indexed keywords

VIRULENCE FACTOR;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; BACTERIUM ADHERENCE; BIOFILM; CROSS INFECTION; DRUG EFFECT; HUMAN; MICROBIOLOGY; MULTIDRUG RESISTANCE; PATHOGENICITY; QUORUM SENSING; REVIEW; TURKEY (REPUBLIC); VIRULENCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BACTERIAL ADHESION; BIOFILMS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; QUORUM SENSING; TURKEY; VIRULENCE; VIRULENCE FACTORS;

EID: 79958699193     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Doi Y, Husain S, Potoski BA, McCurry KR, Paterson DL. Extensively drug-resistant Acinetobacter baumannii. Emerg Infect Dis 2009; 15(6): 980-2.
2. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 2005; 11(11): 868-73.
3. Choi CH, Lee EY, Lee YC, et al. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol 2005; 7(8): 1127-38. (Pubitemid 41030938)
4. Tomaras AP, Dorsey CW, McQueary CN, Actis LA. Molecular basis of Acinetobacter virulence and pathogenecity, pp: 265-97. In: Gerischer U (ed), Acinetobacter Molecular Biology. 2008, Caistr Academic Press, Norfolk, UK.
5. Towner KJ. Acinetobacter. an old friend, but a new enemy. J Hosp Infect 2009; 73(4): 355-63.
6. Nilsson Al, Zorzet A, Kanth A, Dahlstrom S, Berg OG, Andersson Dl. Reducing the fitness cost of antibiotic resistance by amplification of initiator tRNA genes. Proc Nat Acad 2006; 103(18): 6976-98.
7. Lee JC, Koerten H, van den Broek P, et al. Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res Microbiol 2006; 157(4): 360-6.
8. Russo TA, Luke NR, Beanan JM, et al. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun 2010; 78(9): 3993-4000.
9. Pantophlet RA. Lipopolysaccharides of Acinetobacter, pp: 61 -98. In: Gerischer U (ed), Acinetobacter Molecular Biology. 2008, Caistr Academic Press, Norfolk, UK.
10. Lee JC, Oh JY, Kim KS, Jeong YW, Park JC, Cho JW. Apoptotic cell death induced by Acinetobacter baumannii in epithelial cells through caspase-3 activation. APMIS 2001; 109(10): 679-84. (Pubitemid 33020634)
11. Jin JS, Kwon SO, Moon DC, et al. Acinetobacter baumannii secretes cytotoxic outer membrane protein a via outer membrane vesicles. PLoS One 2011; 6(2): e17027.
12. Braun G, Vidotto MC. Evaluation of adherence, hemagglutination, and presence of genes codifying for virulence factors of Acinetobacter baumannii causing urinary tract infection. Mem Inst Oswaldo Cruz 2004; 99(8): 839-44. (Pubitemid 40248982)
13. Cevahir N, Demir M, Kaleli I, Gurbuz M, Tikvesli S. Evaluation of biofilm production, gelatinase activity, and mannose-resistant hemagglutination in Acinetobacter baumannii strains. J Microbiol Immunol Infect 2008; 41(6): 513-8.
14. de Breij A, Gaddy J, van der Meer J, et al. CsuA/BABCDE-dependent pili are not involved in the adherence of Acinetobacter baumannii ATCCI 9606(T) to human airway epithelial cells and their inflammatory response. Res Microbiol 2009; 160(3): 213-8.
15. Sechi LA, Karadenizli A, Deriu A, et al. PER-1 type beta-lactamase production in Acinetobacter baumannii is related to cell adhesion. Med Sci Monit 2004; 10(6): 180-4.
16. Choi CH, Lee JS, Lee YC, Park Tl, Lee JC. Acinetobacter baumannii epithelial cells and outer membrane protein A mediates interactions with epithelial cells. BMC Microbiol 2008; 8: 216.
17. Choi CH, Hyun SH, Lee JY, et al. Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity. Cell Microbiol 2008; 10(2): 309-19.
18. Kim SA, Yoo SM, Hyun SH, et al. Global gene expression patterns and induction of innate immune response in human laryngeal epithelial cells in response to Acinetobacter baumannii outer membrane protein A. FEMS Immunol Med Microbiol 2008; 54(1): 45-52.
19. Lee JS, Lee JC, Lee CM, et al. Outer membrane protein A of Acinetobacter baumannii induces differentiation of CD4+ T cells toward a Th1 polarizing phenotype through the activation of dendritic cells. Biochem Pharmacol 2007; 74(1): 86-97. (Pubitemid 46802485)
20. Gaddy JA, Actis L. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol 2009; 4(3): 273-8.
21. Gordon NC, Wareham DW. Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int J Antimicrob Agents 2010; 35(3): 219-26.
22. Lee HW, Kah YM, Kim J, et al. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect 2008; 14(1): 49-54. (Pubitemid 350226570)
23. Rodríguez-Baño J, Martí S, Soto S, et al. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect 2008; 14(3): 276-8. (Pubitemid 351201019)
24. Reisner A, Krogfelt KA, Klein BM, Zechner EL, Molin S. In vitro biofilm formation of commensal and pathogenic Escherichia coli strains: impact of environmental and genetic factors. J Bacteriol 2006; 188(10): 3572-81. (Pubitemid 43726221)
25. Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology 2003; 149(Pt 12): 3473-84. (Pubitemid 38016675)
26. Gaddy JA, Tomaras AP, Actis LA. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect Immun 2009; 77(8): 3150-60.
27. Wandersman C, Delepelaire P. Bacterial iron sources: from siderophores to hemophores. Annu Rev Microbiol 2004; 58: 611-47. (Pubitemid 39551999)
28. Dorsey CW, Begun MS, Actis LA. Detection and analysis of iron uptake components expressed by Acinetobacter baumannii clinical isolates. J Clin Microbiol 2003; 41(9): 4188-93. (Pubitemid 37099685)
29. Zimbler DL, Penwell WF, Gaddy JA, et al. Iron acquisition functions expressed by the human pathogen Acinetobacter baumannii. Biometals 2009; 22(1): 23-32.
30. Mihara K, Tanabe T, Yamakawa Y, et al. Identification and transcriptional organization of a gene cluster involved in biosynthesis and transport of acinetobactin, a siderophore produced by Acinetobacter baumannii ATCC 19606T. Microbiology 2004; 150(8): 2587-97. (Pubitemid 39177437)
31. Donabedian H. Quorum sensing and its relevance to infectious diseases. J Infect 2003; 46(4): 207-14. (Pubitemid 36758178)
32. Fuqua C, Parsek MR, Greenberg EP. Regulation of gene expession by cell-to-cell communication: acyl-homoserine lactone quorum sensing. Annu Rev Genet 2001; 35: 439-68. (Pubitemid 34032983)
33. Altunçekiç A, Arman D. Acinetobacter cinsi bakterilerin mikrobiyolojisi, direnç mekanizmalari ve çoklu dirençli suslarda tedavl, s: 123-36. Arman D, Ünal S (ed), Yeni ve Yeniden Gündeme Gelen Infeksiyonlar. 2009, 1 .baski. Bilimsel Tip Yayinevi, Ankara.
34. Bhargava N, Sharma P, Capalash N. Quorum sensing in Acinetobacter. an emerging pathogen. Crit Rev Microbiol 2010; 36(4): 349-60.
35. González RH, Dijkshoorn L, Van den Barselaar M, Nudel C. Quorum sensing signal profile of Acinetobacter strains from nosocomial and environmental sources. Rev Argent Microbiol 2009; 41(2): 73-8.
36. Urban C, Segal-Maurer S, Rahal JJ. Considerations in control and treatment of nosocomial infections due to multidrug-resistant Acinetobacter baumannii. Clin Infect Dis 2003; 36: 1268-74. (Pubitemid 36629937)
37. Foumier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006; 42(5): 692-9. (Pubitemid 43271386)